F
Fergus Shanahan
Researcher at National University of Ireland
Publications - 727
Citations - 59181
Fergus Shanahan is an academic researcher from National University of Ireland. The author has contributed to research in topics: Inflammatory bowel disease & Gut flora. The author has an hindex of 117, co-authored 705 publications receiving 51963 citations. Previous affiliations of Fergus Shanahan include Imperial College London & Mater Misericordiae Hospital.
Papers
More filters
Journal ArticleDOI
Culture-independent analysis of desulfovibrios in the human distal colon of healthy, colorectal cancer and polypectomized individuals.
TL;DR: Diversity analysis indicated that a low Desulfovibrio sp.
Journal ArticleDOI
A randomized controlled study of mesalamine after acute diverticulitis: Results of the DIVA trial
TL;DR: In the first US randomized placebo-controlled trial of anti-inflammatory treatment after a documented case of diverticulitis, mesalamine demonstrated a consistent trend in reducing symptoms.
Journal ArticleDOI
The evolving epidemiology of inflammatory bowel disease.
TL;DR: Advances in understanding the basic biology of IBD with rapidly emerging therapeutic strategies have prompted a shift in traditional epidemiologic approaches away from risk factor anthologies toward rapprochement with disease mechanisms and pursuit of changing patterns of comorbidity of clinical relevance.
Journal ArticleDOI
Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption.
Ian B. Jeffery,Anubhav Das,E.A. O'Herlihy,Simone Coughlan,Katryna Cisek,Michael Moore,Fintan Bradley,Tom Carty,Meenakshi Pradhan,Chinmay Kumar Dwibedi,Fergus Shanahan,Fergus Shanahan,Paul W. O'Toole,Paul W. O'Toole +13 more
TL;DR: Fecal metabolome analysis can be used to distinguish patients with IBS with vs without BAM, and these findings might be use to develop microbe-based treatments for these disorders.
Journal ArticleDOI
Micrometastases: marker of metastatic potential or evidence of residual disease?
Gerald C. O'Sullivan,John Kevin Collins,J Kelly,John G. Morgan,Michael Madden,Fergus Shanahan +5 more
TL;DR: Although fewer metastatic cells were detected in postoperative bone marrow, and clearance of marrow deposits was evident in most patients, the persistence of micrometastases in five of 16 patients after resection, without evidence of tumour recurrence, indicates a subset with true residual disease.